Product Code: ETC8846591 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neuroblastoma market in the Philippines is focused on the treatment and management of this rare pediatric cancer. Advances in chemotherapy, radiation therapy, and immunotherapy are improving survival rates. Increased awareness and early diagnosis are key factors driving market growth, while ongoing research in targeted therapies is expected to provide new treatment avenues.
The increasing incidence of pediatric cancers, including neuroblastoma, is a key driver of this market in the Philippines. Advances in early cancer detection and the availability of targeted therapies contribute to improved patient outcomes. Additionally, government initiatives supporting cancer research and access to specialized pediatric oncology care drive market growth.
The neuroblastoma market in the Philippines struggles with early detection and treatment accessibility. Pediatric neuroblastoma cases are often diagnosed at later stages due to limited awareness and a lack of specialized pediatric oncology centers. High treatment costs and limited availability of advanced therapies also pose significant barriers to patient survival and recovery.
Neuroblastoma, a rare but serious childhood cancer, has created investment opportunities in oncology research and treatment solutions in the Philippines. Companies specializing in immunotherapy, targeted drug development, and early detection methods can find growth opportunities. Collaboration with pediatric oncology centers and government health initiatives can further drive innovation in neuroblastoma treatment.
The government has established policies to improve pediatric cancer treatment, including neuroblastoma. The National Integrated Cancer Control Act ensures that children with neuroblastoma receive early diagnosis and access to comprehensive care. Public hospitals are mandated to provide free or subsidized cancer treatment, including chemotherapy and radiation therapy. Research collaborations with global institutions are encouraged to advance treatment options for childhood cancers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Neuroblastoma Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Neuroblastoma Market - Industry Life Cycle |
3.4 Philippines Neuroblastoma Market - Porter's Five Forces |
3.5 Philippines Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Philippines Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Philippines Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Neuroblastoma Market Trends |
6 Philippines Neuroblastoma Market, By Types |
6.1 Philippines Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Philippines Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Philippines Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Philippines Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Philippines Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Philippines Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Philippines Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Philippines Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Philippines Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Philippines Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Philippines Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Philippines Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Philippines Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Philippines Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Philippines Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Philippines Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Philippines Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Neuroblastoma Market Import-Export Trade Statistics |
7.1 Philippines Neuroblastoma Market Export to Major Countries |
7.2 Philippines Neuroblastoma Market Imports from Major Countries |
8 Philippines Neuroblastoma Market Key Performance Indicators |
9 Philippines Neuroblastoma Market - Opportunity Assessment |
9.1 Philippines Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Philippines Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Philippines Neuroblastoma Market - Competitive Landscape |
10.1 Philippines Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Philippines Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |